Qiagen NV | QIA - Current Assets


Qiagen NV reported $1.54B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 229.55M 13.93M Jun/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
argenx SE USD 8.07B 1.17B Jun/2026
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Moderna USD 5.82B 45M Jun/2026
Organon & Co USD 4.93B 580M Mar/2026
Qiagen NV USD 1.54B 454.82M Mar/2026
Revvity USD 2.3B 169.4M Jun/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026